Arthritis & Rheumatology

Article	Citations
Clinical Images: Rice bodies in pseudogout	635
In This Issue	505
At the Heart of Treating Kawasaki Disease: The Search for New Approaches to Prevent Coronary Artery Aneurysms	360
Association of change in metabolic syndrome status with altered risk of incident gout: comment on the article by Eun et al	352
Tissue‐Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis	222
Targeting the Myddosome in Systemic Autoimmunity: Ready for Prime Time?	193
In This Issue	172
Disturbed Spatial WNT Activation—A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis	145
COVID‐19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settings	138
Pregnancy Outcomes in Women With Psoriatic Arthritis in Relation to Presence and Timing of Antirheumatic Treatment	135
	131
Reply	130
Possible confounding factors explaining data on heart failure risk in patients with polymyositis/dermatomyositis: comment on the article by Lin et al	126
Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin‐2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus	124
Sex Differences in B Cells from the Joints of Children with Oligoarticular Juvenile Idiopathic Arthritis	124
The Devil Is in the Detail: Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty	119
Seronegative palindromic rheumatism: what are we talking about? Comment on the article by Yang et al	116
	105
The Evolving Role of the Rheumatology Practitioner in the Care of Immunocompromised Patients in the COVID‐19 Era	104
Clinical Connections	103
CCL19‐Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor Kinase	100
Clinical Connections	99
Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide	94
Higher alcohol consumption was associated with greater incidence of total hip replacement due to hip osteoarthritis in a dose‐dependent manner in women: comment on the article by Marchand et al	94
	93

Systemic lupus erythematosus and atherosclerosis progression risk: comment on the article by Papazoglou et al.	91
Endogenous Retroelement Activation is Implicated in Interferon‐α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis	85
Minimal tofacitinib dose for maintenance in axial spondyloarthritis: real‐world data from a resource‐limited setting	83
No differences in myocardial perfusion between treatment‐naive, early rheumatoid arthritis patients and healthy controls	82
Gut Microbiome and Osteoarthritis: Insights From the Naturally Occurring Canine Model of Osteoarthritis	78
Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool (PRESTO): A Step Towards Prevention	78
Using Mice to Model Human Osteoarthritis: Age, Biologic Sex, and Pain Matter	78
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases	74
Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis	72
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Tr	72
A methodologic problem and a conceptual issue related to the new 2022 antineutrophil cytoplasmic antibody–related vasculitis criteria sets: comment on criteria sets approved by the American College of	71
Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population‐Based Study Over Four Decades Using the Lupus Midwest Network	69
Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis	65
Phase III/IV, Randomized, Fifty‐Two–Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus	61
Interleukin‐13 Receptor α1–Mediated Signaling Regulates Age‐Associated/Autoimmune B Cell Expansion and Lupus Pathogenesis	60
Identification of Shared and Asian‐Specific Loci for Systemic Lupus Erythematosus and Evidence for Roles of Type III Interferon Signaling and Lysosomal Function in the Disease: A	60
The Interleukin‐1 Receptor–Associated Kinase 4 Inhibitor PF‐06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial	59
Contribution of Interleukin‐4–Induced Epithelial Cell Senescence to Glandular Fibrosis in IgG4‐Related Sialadenitis	59
Knee Alignment Correction by High Tibial Osteotomy Reduces Symptoms and Synovial Inflammation in Knee Osteoarthritis Accompanied by Macrophage Phenotypic Change From M1 to M2	59
Alteration of Gut Microbiota in Individuals at High‐Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immu	58
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial	58
Correction to “Novel Genetic Loci in Early‐Onset Gout Derived From Whole‐Genome Sequencing of an Adolescent Gout Cohort”	55
Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthr	52
Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy	51
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria	50
NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2‐Mediated Pyroptosis Through the Phosphorylated Salt‐Inducible Kinase 1/Sterol Regulatory Element Binding T	50
Journal Club	49
Issue Information	48
In This Issue	48
Not Only Excruciating Pain: Might a Gout Flare Episode Lead to Pulmonary Embolism?	48
Reply	47
Clinical Connections	47
Reply	47
	46
ACR Announcements	46
Reply	46
Reply	45
	45
Reply	45
Clinical Connections	44
Reply	44
Immuno‐Autonomics as a Complement to Precision Medicine Guiding Treatment of Patients With Rheumatoid Arthritis: Comment on the Article by Tao et al	44
Effects of Anti–Tumor Necrosis Factor Therapy on Osteoblastic Activity at Sites of Inflammatory and Structural Lesions in Radiographic Axial Spondyloarthritis: A Prospective Proof‐of‐Concept	44
Journal Club	44
Winner of the 2021 American College of Rheumatology Annual Image Competition	44
Immediate Open Access: The Good, the Bad, and the Impact on Academic Society Publishing	44
Reply	44
Role of autoantibodies in lupus nephritis: comment on the article by Fava et al	43
Development and External Validation of a Model Predicting New‐Onset Chronic Uveitis at Different Disease Durations in Juvenile Idiopathic Arthritis	43
Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis	41

Lysosome‐Associated Membrane Protein 3 Induces Lysosome‐Dependent Cell Death by Impairing Autophagic Caspase 8 Degradation in the Salivary Glands of Individuals With Sjögren's Di	41
Oxidative Stress by the Mitochondrial Monoamine Oxidase B Mediates Calcium Pyrophosphate Crystal–Induced Arthritis	41
Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis–Associated Lymphoproliferative Disorders	41
	40
Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib	40
Transcriptomic Evaluation of Juvenile Localized Scleroderma Skin With Histologic and Clinical Correlation	40
Effects of Secukinumab on Enthesiophyte and Erosion Progression in Psoriatic Arthritis: A One‐Year Double‐Blind, Randomized, Placebo‐Controlled Trial Using High‐Resolution Peripheral Quantitative Comp	40
In This Issue	39
No Added Value of Duloxetine in Patients With Chronic Pain due to Hip or Knee Osteoarthritis: A Cluster‐Randomized Trial	39
Reply	39
Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling	39
Journal Club	39
Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease Pathology	39
Issue Information	38
Clinical Image: Nasal rim sign: A clinical manifestation of dermatomyositis	38
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb<	38
Revisiting the Synovium as a Structural Correlate of Pain in Osteoarthritis	37
Using Two Predictive Models to Capture Two Types of Poor Outcomes in Knee Arthroplasty: A Multisite Longitudinal Cohort Study	37
Vertebral Bone Mineral Density, Vertebral Strength, and Syndesmophyte Growth in Ankylosing Spondylitis: The Importance of Bridging	37
Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells, Which Enhances Transforming Growth Factor β1 Activation and Promotes Tissue Fibrosis in Patients With Lupus Nephritis	37
Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits	36
	36
Variability of Primary Sjögren's Syndrome Is Driven by Interferon‐α and Interferon‐α Blood Levels Are Associated With the Class II HLA–DQ Locus	35
Critical Role of Notch‐1 in Mechanistic Target of Rapamycin Hyperactivity and Vascular Inflammation in Patients With Takayasu Arteritis	35
Superiority of Low‐Dose Benzbromarone to Low‐Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion	35
The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New‐Onset Rheumatoid Arthritis	35
Notch‐1 and Notch‐3 Mediate Hypoxia‐Induced Activation of Synovial Fibroblasts in Rheumatoid Arthritis	34
Urate Lowering for Blood Pressure Control in Adults: Another Nail in the Coffin?	34
The genetic contribution of inflammation to the increased risk of cardiovascular disease in rheumatoid arthritis: comment on the article by Yuan et al	34
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome	34
Reply	34
Prediction of Differential Pharmacologic Response in Chronic Pain Using Functional Neuroimaging Biomarkers and a Support Vector Machine Algorithm: An Exploratory Study	33
In This Issue	33
Reply	33
Clinical Images: Burton line and scar hyperpigmentation in a patient with severe lead poisoning and saturnine gout	33
Reply	32
	32
Reply	32
Corrigendum	31
Trends in New Use of Disease‐Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022	31
A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis	31
Clinical Images: Increased bone metabolism in secondary hyperparathyroidism	31
Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups	31
Issue Information ‐ General Info	31
Serum Urate–Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Trial	31
Artificial Intelligence and Deep Learning for Rheumatologists	30
Reply	30
Programmed Death Ligand 1–Expressing Macrophages and Their Protective Role in the Joint During Arthritis	30
Global Rheumatology Research: Frontiers, Challenges, and Opportunities	30
Reply	30
Role of Human Mesenchymal Stem Cells and Derived Extracellular Vesicles in Reducing Sensory Neuron Hyperexcitability and Pain Behaviors in Murine Osteoarthritis	30
Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel	30
Estrogen‐Induced hsa‐miR‐10b‐5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down‐Regulates Serine/Arginine‐Rich Splicing Factor 1	30
Clinical Connections	29
Clinical Images: Transient perivascular inflammation of the carotid artery syndrome	29
Heightened Proinflammatory Glycosylation of Borrelia burgdorferi IgG Antibodies in Synovial Fluid in Patients With Antibiotic‐Refractory Lyme Arthritis	29
Acute Digital Necrosis Due to Interferon‐α–Induced Antineutrophil Cytoplasmic Antibody–Associated Vasculitis	29
Journal Club	29
Changes in Descending Pain Modulation During Anti–Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and Spondyloarthritis	29
Clinical Connections	29
Screening of Environmental Chemicals to Characterize Exposures in Participants With Systemic Lupus Erythematosus	28
The Efficacy of Short‐Term Bridging Strategies With High‐ and Low‐Dose Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A Double‐Blin	28
An investigation of the relationship between weight management and gout: insights from the THIN database study and recommendations for improvement. Comment on the article by Wei et al	28
Choosing to End African American Health Disparities in Patients With Systemic Lupus Erythematosus	28
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis	28
Clinical images: VEXAS syndrome presenting as treatment‐refractory polyarteritis nodosa	28
Hydroxychloroquine dose after hospitalization for systemic lupus erythematosus: comment on the article by Nestor et al	28
Doctor versus artificial intelligence: patient and physician evaluation of large language model responses to rheumatology patient questions: comment on the article by Ye et al	28
A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease	28
	27
Reply	27
Concerns Regarding P Value‐Based Variable Selection of Exposure Variables and Confounding Factors: Comment on the Article by Hawker et al	27
Hypoxia‐Induced Synovial Fibroblast Activation in Inflammatory Arthritis and the Role of Notch‐1 and Notch‐3 Signaling: Comment on the Article by Chen et al	27
Local Ancestry at the Major Histocompatibility Complex Region is Not a Major Contributor to Disease Heterogeneity in a Multiethnic Lupus Cohort	27
Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: Are the Visual Outcomes Different From Giant Cell Arteritis? Comment on the Article by Delaval et al	27
Skeletal Muscle Composition, Power, and Mitochondrial Energetics in Older Men and Women With Knee Osteoarthritis	27
Do We Need More Exercise and Osteoarthritis Randomized Clinical Trials?	27
Reply	27
Issue Information ‐ TOC	27
Erratum	27

Transforming Rheumatology Practice With Technology: Products, Processes, People, and Purpose	26
Clinical Connections	26
Addressing readability of online patient materials: comment on the American College of Rheumatology online information pages for patients and caregivers	26
Reply	26
Critical role for Transglutaminase 2 in scleroderma skin fibrosis and in the development of dermal sclerosis in a mouse model of scleroderma	26
Clinical images: Huriez syndrome, a rare scleroderma mimic	26
Issue Information	26
Issue Information ‐ TOC	26
Should lipoprotein(a) be routinely measured after COVID‐19? Comment on the article by Stahl et al	26
Weight Reduction and Target Serum Urate Level: A Longitudinal Study of Annual Medical Examination	25
Cartilage Acidic Protein 1 in Plasma Associates With Prevalent Osteoarthritis and Predicts Future Risk as Well as Progression to Joint Replacements: Results From the UK Biobank Resource	25
	25
Correspondence and comments on American College of Rheumatology and EULAR antiphospholipid syndrome classification criteria: comment on the article by Barbhaiya et al	25
Reply	25
Reply	25
Adverse Events of Special Interest Incorrectly Referred to As Serious Adverse Events of Special Interest in the Article by Chatham et al(Arthritis Rheumatol, May 2021)	25
Journal Club	25
The oral microbiota in persons at risk for rheumatoid arthritis: follow‐up data	24
Mapping and Analysis of Protein and Gene Profile Identification of the Important Role of Transforming Growth Factor Beta in Synovial Invasion in Patients With Pigmented Villonodular Synovitis	24
Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis	24
Promotion of Joint Degeneration and Chondrocyte Metabolic Dysfunction by Excessive Growth Hormone in Mice	24
Retraction	24
Journal Club	24
Plasma Proteomic Profiles Predict Individual Future Osteoarthritis Risk	24
Host Genetics But Not Commensal Microbiota Determines the Initial Development of Systemic Autoimmune Disease in BXD2 Mice	24
Strength Training is Associated With Less Knee Osteoarthritis: Data From the Osteoarthritis Initiative: Comment on the Article by Lo et al	24
Concordance between ultrasound and physical examination in enthesitis assessment: a call for further investigation: comment on the article by Di Matteo et al	24
Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comor	24
Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis–Associated Interstitial Lung Disease	24
Genome‐Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim‐Chester Disease	24
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3	24
The Transition From Residency to Fellowship: Enhancing Training by Increasing Transparency	23
Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease	23
Predictors of Rheumatic Immune‐Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer	23
Clinical and Methodologic Considerations With Regard to a Trial of Nintedanib in Patients With Systemic Sclerosis‐Associated Interstitial Lung Disease: Comment on the Reanalysis by Maher et al	23
Efficacy and Safety of Diclofenac–Hyaluronate Conjugate (Diclofenac Etalhyaluronate) for Knee Osteoarthritis: A Randomized Phase III Trial in Japan	23
Association of 18F‐Fluorodeoxyglucose–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis	23
Increased risk of statin‐associated autoimmune myopathy among American Indians	23
Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis	23
Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al	23
Complement	23
Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response	23
Reply	23
Reply	22
Reply	22
Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities	22
	22
Rheumatology Is Amazing	22
Phenotype Risk Score but Not Genetic Risk Score Aids in Identifying Individuals With Systemic Lupus Erythematosus in the Electronic Health Record	22
	22
Clinical Connections	22
The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids	22
Risk of arrhythmia among new users of hydroxychloroquine: comment on the article by Hoque et al	22
Issue Information	22
Giant Iliopsoas Bursitis in Systemic Juvenile Idiopathic Arthritis	22
Novel Majeed Syndrome–CausingLPIN2Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis	22
Clinical Connections	22
Risk of serious infection between belimumab and oral immunosuppressants for non‐renal systemic lupus erythematosus: comment on the article by Materne et al	22
In This Issue	22
Association of alcohol consumption with disease activity and health‐related quality of life in rheumatoid arthritis: comment on the article by Alfredsson et al	22
Should Low Serum Urate Be Exonerated? Untangling the Influence of Sarcopenia in Observational Studies	22
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?	22
Genetic Association of a Gain‐of‐Function IFNGR1 Polymorphism and the Intergenic Region LNCAROD/DKK1 With Behçet’s Disease	22
Weighing the Cardiovascular Risks of Low‐Dose Glucocorticoids in Rheumatoid Arthritis From Real‐World Data	22
The Characteristics of Patients With COVID‐19–Associated Pediatric Vasculitis: An International, Multicenter Study	21
Diversity and Epitope Spreading of Anti–RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement	21
A Novel Human Interleukin‐23A Overexpressing Mouse Model of Systemic Lupus Erythematosus	21
Identification of Novel Loci Shared by Juvenile Idiopathic Arthritis Subtypes Through Integrative Genetic Analysis	21
Reply	21
	21
Single‐Cell Profiling of Bone Marrow B Cells and Early B Cell Developmental Disorders Associated With Systemic Lupus Erythematosus	21
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data	21
Journal Club	21
Impaired Efferocytosis by Synovial Macrophages in Patients With Knee Osteoarthritis	20
Genetic Architecture of Idiopathic Inflammatory Myopathies From Meta‐Analyses	20
A Genome‐Wide Association Study Meta‐Analysis of Alpha Angle Suggests Cam‐Type Morphology May Be a Specific Feature of Hip Osteoarthritis in Older Adults	20
A Randomized, Placebo‐Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings	20
Clinical Images: Erdheim‐Chester disease presenting with palpitations and spondylopathy	20
ChatGPT, et al…Artificial Intelligence, Authorship, and Medical Publishing	20
Increased Diagnostic Accuracy of the Labial Gland Biopsy in Primary Sjögren Syndrome When Multiple Histopathological Features Are Included	20
Urinary Biomarkers Associated With Pathogenic Pathways Reflecting Histologic Findings in Lupus Nephritis	20
Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides	20
Baricitinib Improves Bone Properties and Biomechanics in Patients With Rheumatoid Arthritis: Results of the Prospective Interventional BARE BONE Trial	20
Gout and Excess Risk of Severe SARS–CoV‐2 Infection Among Vaccinated Individuals: A General Population Study	19
Expert Perspectives on a Clinical Challenge: Hematologic Malignancies and Vasculitis	19
Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis	19
Plasmablast‐like Phenotype Among Antigen‐Experienced CXCR5–CD19low B Cells in Systemic Lupus Erythematosus	19
Epicardial Adipose Tissue Volume As a Marker of Subclinical Coronary Atherosclerosis in Rheumatoid Arthritis	19
Long‐Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor–Associated Periodic Syndrome: Results From a Phase III Trial	19
Multimodal Single‐Cell Sequencing of B Cells in Primary Sjögren's Syndrome	19
Platelet Phagocytosis via P‐selectin Glycoprotein Ligand 1 and Accumulation of Microparticles in Systemic Sclerosis	19
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis	19
Association of a Combination of Healthy Lifestyle Behaviors With Reduced Risk of Incident Systemic Lupus Erythematosus	19
Amelioration of Posttraumatic Osteoarthritis in Mice Using Intraarticular Silencing of Periostin via Nanoparticle‐Based Small Interfering RNA	19
The effect of air pollution and genetic susceptibility on systemic lupus erythematosus: comment on the article by Xing et al	19